- $205.05m
- $158.10m
- $935.82m
- 79
- 97
- 57
- 92
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 687 | 767 | 1,016 | 992 | 936 |
Cost of Revenue | |||||
Gross Profit | 142 | 165 | 240 | 193 | 185 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 702 | 757 | 1,023 | 1,006 | 922 |
Operating Profit | -14.6 | 10.2 | -7.49 | -13.5 | 14 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -15 | 7.65 | -14.5 | -18.6 | 16.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -20.5 | 4.36 | 11 | -24.6 | 10.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -20.5 | 4.36 | 11 | -24.6 | 10.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -20.5 | 1.67 | 11 | -24.6 | 10.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.508 | -0.104 | 0.638 | -0.425 | -0.03 |
Dividends per Share |